Vascular endothelial growth factor (VEGF) induces osteoclast differentiation as well as neovascularization by binding to the fms-like tyrosine kinase (Flt)-1 and fetal liver kinase (Flk)-1 receptors. The Flt-4 receptor also plays an important role in angiogenesis and lymphangiogenesis. The purpose of this study was to investigate the functions of Flt-4 in the signaling pathway of osteoclast differentiation. We examined the expression of Flt-4 on osteoclast precursor cells (OCPs), and the ability of recombinant human (rh) VEGF-D, one of the ligands of Flt-4, to stimulate the phosphorylation of extracellular-regulated kinase1/2 (ERK1/2) and to activate the nuclear factor-kappa B (NF-κB) pathway in OCPs. The number of osteoclasts induced by injection of rhVEGF-D in osteopetrotic (op/op) mice was also evaluated in the absence or presence of neutralizing antibodies to Flt-4. Flt-4 expression was detected on OCPs at both gene and protein levels and stimulation of Flt-4 by rhVEGF-D might induce activation of mitogen-activated protein kinase (MAPK) and NF-κB pathways for induction of osteoclast differentiation. Moreover, the number of osteoclasts in op/op mice increased after injection of rhVEGF-D, but was significantly reduced by the injection of Flt-4 neutralizing antibodies. We have therefore shown that Flt-4 expressed on OCPs, might activate MAPK and NF-κB pathways and played an important role in osteoclast differentiation.Vascular endothelial growth factor (VEGF) can induce neovascularization (15). Two specific tyrosine kinase receptors for VEGF have been identified, namely the fms-like tyrosine kinase (Flt)-1 and fetal liver kinase (Flk)-1 which are specifically expressed on vascular endothelial cells and mature osteoclasts (4,16,19). Furthermore, previous studies have demonstrated that recombinant human (rh) VEGF can induce the production of a large number of osteoclasts in osteopetrotic (op/op) mice (17). These mice are characterized by a deficiency in osteoclasts, monocytes, and macrophages that is caused by the absence of a functional macrophage-colony stimulating factor (M-CSF) (6,10,17,22,23). These findings indicate that the VEGF signaling pathway leading to osteoclast differentiation involves signaling through both of these VEGF receptors. Orthodontic tooth movement and related tissue remodeling are achieved by osteoclastic bone resorption followed by osteoblastic new bone formation. Our recent study has demonstrated that VEGF is expressed by osteoblasts located on the tension side of the alveolar bone during experimental tooth movement (12). Furthermore, the number of osteoclasts and the amount of tooth movement were enhanced